Home › Hemophilia › California › San Francisco
Hemophilia clinical trials in San Francisco, CA
3 studies for Hemophilia are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
RecruitingPhase 1/2
- University of California San Francisco, San Francisco
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- University of California, San Francisco Hemophilia & Thrombosis Center, San Francisco
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
RecruitingPhase 3
- UCSF Outpatient Hematology Clinic, San Francisco
About Hemophilia
Hemophilia is a rare disorder in which the blood does not clot normally. Usually hemophilia usually occurs in males and is inherited. Learn more.
More about Hemophilia on MedlinePlus
Hemophilia trials in other cities
- Indianapolis, IN8 studies
- Los Angeles, CA7 studies
- Cedar Rapids, IA6 studies
- Seattle, WA6 studies
- Philadelphia, PA5 studies
- Little Rock, AR4 studies
- Atlanta, GA4 studies
- Sacramento, CA4 studies
- Greenville, NC4 studies
- Orange, CA4 studies
- Tampa, FL4 studies
- San Antonio, TX3 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer29 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Colorectal Cancer19 studies
- Cardiovascular Disease18 studies
- Ovarian Cancer18 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.